• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Development of Sustainable Bioprocesses. Modeling and Assessment - Product Image

Development of Sustainable Bioprocesses. Modeling and Assessment

  • ID: 2252106
  • November 2006
  • 316 Pages
  • John Wiley and Sons Ltd

Bioprocess technology involves the combination of living matter (whole organism or enzymes ) with nutrients under laboratory conditions to make a desired product within the pharmaceutical, food, cosmetics, biotechnology, fine chemicals and bulk chemicals sectors. Industry is under increasing pressure to develop new processes that are both environmentally friendly and cost-effective, and this can be achieved by taking a fresh look at process development; - namely by combining modern process modeling techniques with sustainability assessment methods.

Development of Sustainable Bioprocesses: Modeling and Assessment describes methodologies and supporting case studies for the evolution and implementation of sustainable bioprocesses. Practical and industry-focused, the book begins with an introduction to the bioprocess industries and development procedures. Bioprocesses and bioproducts are then introduced, together with a description of the unit operations involved. Modeling procedures, a key feature of the book, are covered in chapter 3 prior to an overview of the key sustainability assessment methods in use (environmental, economic and societal). The second part of the READ MORE >

Note: Product cover images may vary from those shown



List of Contributors.

Part I: Theoretical Introduction.

1. Introduction.

1.1. Bioprocesses.

1.2. Modeling and Assessment in Process Development.

2. Development of Bioprocesses.

2.1. Types of Bioprocesses and Bioproducts.

2.2. Bioreaction Stoichiometry, Thermodynamics and Kinetics.

2.3. Elements of Bioprocesses (Unit Operations and Unit Processes).

2.4. The Development Process.

3. Modeling and Simulation of Bioprocesses.

3.1. Problem Structuring, Process Analysis and Process Scheme.

3.2. Implementation and Simulation.

3.3. Uncertainty Analysis.

4. Sustainability Assessment.

4.1. Sustainability.

4.2. Economic Assessment.

4.3. Environmental Assessment.

4.4. Assessing Social Aspects.

4.5. Interactions Between the Sustainability Dimensions.

Part II: Bioprocess Case Studies.

Introduction to Case Studies 

5. Citric Acid - Alternative Process Using Starch.

5.1. Introduction.

5.2. Fermentation Model.

5.3. Process Model.

5.4. Inventory Analysis.

5.5. Environmental Assessment.

5.6. Economic Assessment.

5.7. Conclusions.

6. Pyruvic Acid - Fermentation with Alternative Downstream Processes.

6.1. Introduction.

6.2. Fermentation Model.

6.3. Process Model.

6.4. Inventory Analysis.

6.5. Environmental Assessment.

6.6. Economic Assessment.

6.7. Conclusions.

7. L-Lysine - Coupling of Bioreaction and Process Model.

7.1. Introduction.

7.2. Basic Strategy.

7.3. Bioreaction Model.

7.4. Process Model.

7.5. Coupling of Bioreaction and Process Model.

7.6. Results and Discussion.

8. Riboflavin – Vitamin B2.

8.1. Introduction.

8.2. Biosynthesis and Fermentation.

8.3. Production Process and Process Model.

8.4. Inventory Analysis.

8.5 Ecological Assessment.

8.6 Economic Assessment.

8.7 Discussion and Concluding Remarks.

9. a-Cyclodextrin.

9.1. Introduction.

9.2. Reaction Model.

9.3. Process Model.

9.4. Inventory Analysis.

9.5. Environmental Assessment.

9.6. Economic Assessment.

9.7. Conclusions.

10. Penicillin V.

10.1. Introduction.

10.2. Modeling Base Case.

10.3. Inventory Analysis.

10.4. Environmental Assessment.

10.5. Economic Assessment.

10.6. Monte Carlo Simulations.

10.7. Conclusions.

11. Recombinant Human Serum Albumin.

11.1. Introduction.

11.2. Bioreaction Model.

11.3. Process Model.

11.4. Economic Assessment.

11.5. Ecological Assessment.

11.6. Conclusions.

12. Recombinant Human Insulin.

12.1. Introduction.

12.2. Market Analysis and Design Basis.

12.3. Economic Assessment.

12.4. Throughput Increase Options.

12.5. Conclusions.

13. Monoclonal Antibodies.

13.1. Introduction.

13.2. Process Model.

13.3. Inventory Analysis.

13.4. Economic Assessment.

13.5. Environmental Assessment.

13.6. Uncertainty Analysis.

13.6. Conclusions.

14. a-1-Antitrypsin from Transgenic Plant Cell Suspension Cultures.

14.1. Introduction.

14.2. Process Description.

14.3. Model Description.

14.4. Discussion.

14.5 Conclusions.

15. Plasmid DNA.

15.1. Introduction.

15.2. Model Description.

15.3. Inventory Analysis.

15.4. Economic Assessment.

15.5. Environmental Assessment.

15.6. Discussion.

15.7. Conclusions.


Note: Product cover images may vary from those shown

Professor Elmar Heinzle, Universität des Saarlandes, Germany

Dr. Charles Cooney, MIT, USA

Both internationally-recognised experts in biochemical engineering and modeling

Dr Arno Biwer, MIT/ Universität des Saarlandes, Germany

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Our clients' logos